Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 3
Study Completion Date
January 2014
NCT00433511Uploaded 02-09-2020
Access via NCI by Request
PDS UID: nci-data-398
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Files: NCT00433511-D2
Data DictionaryNCT00433511-D2-Data-Dictionary_2.pdf
DATANCT00433511-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00433511-D1
Data DictionaryNCT00433511-D1-Data-Dictionary_2.pdf
DATANCT00433511-D1-Dataset_1.csv
OTHERREADME.pdf
Files: NCT00433511-D4
Data DictionaryNCT00433511-D4-Data-Dictionary_1.pdf
DATANCT00433511-D4-Dataset.csv
OTHERREADME.pdf